Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;85:635-647

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Epstein, N. D.
Right arrow Articles by Leppert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Epstein, N. D.
Right arrow Articles by Leppert, M.

Circulation, Vol 85, 635-647, Copyright © 1992 by American Heart Association


ARTICLES

Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy

ND Epstein, L Fananapazir, HJ Lin, J Mulvihill, R White, JM Lalouel, RP Lifton, AW Nienhuis and M Leppert
Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

BACKGROUND. Recently, two families with hypertrophic cardiomyopathy have been shown to have mutations in the cardiac beta-myosin heavy chain gene (beta-MHC) located on the long arm of chromosome 14. METHODS AND RESULTS. We have performed linkage analysis of five newly ascertained pedigrees with more than 50 chromosomal markers detecting polymorphisms. Our findings confirm the linkage to beta-MHC gene locus on chromosome 14 in one family (LOD score, 4.50) and suggest linkage to the same gene in another kindred. Chromosome 14 markers were not linked to the disease gene in the other three kindreds, however, and a test for genetic heterogeneity was statistically significant. Moreover, markers for the beta-MHC gene identified affected individuals who were recombinants with respect to this gene and the disease phenotype in these three kindreds. CONCLUSIONS. These results provide conclusive evidence that hypertrophic cardiomyopathy in separate families is caused by mutations in disease genes at two or more locations in the genome.


This article has been cited by other articles:


Home page
CirculationHome page
A.J. Marian and R. Roberts
Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy
Circulation, September 1, 1995; 92(5): 1336 - 1347.
[Full Text]


Home page
CirculationHome page
K. Schwartz, L. Carrier, P. Guicheney, and M. Komajda
Molecular Basis of Familial Cardiomyopathies
Circulation, January 15, 1995; 91(2): 532 - 540.
[Full Text]


Home page
NEJMHome page
D. P. Kelly and A. W. Strauss
Inherited Cardiomyopathies
N. Engl. J. Med., March 31, 1994; 330(13): 913 - 919.
[Full Text]